Maltin Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,096
Closed -$227K 143
2025
Q4
$227K Buy
+1,096
New +$217K 0.09% 121
2024
Q4
Sell
-1,305
Closed -$212K 130
2024
Q3
$212K Buy
+1,305
New +$208K 0.1% 121
2024
Q2
Sell
-1,290
Closed -$204K 123
2024
Q1
$204K Sell
1,290
-29
-2% -$4.62K 0.11% 118
2023
Q4
$207K Sell
1,319
-3,793
-74% -$582K 0.13% 112
2023
Q3
$796K Sell
5,112
-5
-0.1% -$825 0.56% 59
2023
Q2
$847K Buy
5,117
+6
+0.1% +$968 0.6% 56
2023
Q1
$792K Buy
5,111
+130
+3% +$21K 0.57% 56
2022
Q4
$880K Sell
4,981
-1,901
-28% -$328K 0.64% 49
2022
Q3
$1.12M Sell
6,882
-1
-0% -$169 0.89% 40
2022
Q2
$1.22M Buy
6,883
+22
+0.3% +$3.92K 0.88% 40
2022
Q1
$1.22M Buy
6,861
+2,502
+57% +$426K 0.8% 44
2021
Q4
$746K Buy
4,359
+627
+17% +$103K 0.45% 66
2021
Q3
$603K Buy
3,732
+39
+1% +$6.65K 0.37% 64
2021
Q2
$608K Sell
3,693
-684
-16% -$113K 0.37% 65
2021
Q1
$719K Sell
4,377
-128
-3% -$20.7K 0.47% 54
2020
Q4
$709K Buy
+4,505
New +$665K 0.5% 49
2020
Q2
Sell
-3,738
Closed -$490K 87
2020
Q1
$490K Buy
+3,738
New +$530K 0.42% 51

Other funds holding JNJ

Maltin Wealth Management's JNJ Position: Q1 2026 in Review

Maltin Wealth Management sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 1,096 shares — an estimated $227K sold.

Maltin Wealth Management first reported a position in JNJ in Q1 2020 and held it in 17 quarters. The position peaked at $1.22M in Q2 2022. 4,641 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Maltin Wealth Management reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Maltin Wealth Management sold 1,096 Johnson & Johnson shares in Q1 2026, an estimated $227K.
  • Maltin Wealth Management first reported a position in Johnson & Johnson in Q1 2020 and held it in 17 quarters.
  • Maltin Wealth Management's Johnson & Johnson position peaked at $1.22M in Q2 2022.
  • 4,641 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Maltin Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.